tiprankstipranks
GeneThera Inc (GTHR)
OTHER OTC:GTHR
US Market

GeneThera (GTHR) Income Statement

Compare
1 Followers

GeneThera Income Statement

Last quarter (Q3 2023), GeneThera's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, GeneThera's net income was $0.00. See GeneThera’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -5.28K$ -5.28K$ -5.28K$ -5.28K
Operating Expenses
$ 0.00$ 1.01M$ 740.61K$ 739.15K$ 3.93M
Depreciation and Amortization
$ 228.49K$ 5.28K$ 5.28K$ 5.28K$ 5.28K
EBITDA
$ 0.00$ -1.00M$ -735.33K$ -733.87K$ -3.92M
Operating Income
$ 0.00$ -1.01M$ -740.61K$ -739.15K$ -3.93M
Other Income/Expenses
$ 0.00$ -2.22K$ -33.85K$ 221.50K$ 530.38K
Pretax Income
$ 0.00$ -1.01M$ -774.46K$ -517.65K$ -4.04M
Net Income
$ 0.00$ -1.01M$ -808.32K$ -546.23K$ -4.04M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ -0.04$ -0.04$ -0.02$ -0.11
Diluted EPS
$ 0.00$ -0.04$ -0.04$ -0.02$ -0.11
Weighted Average Shares Outstanding
0.00 25.35M 20.31M 35.90M 38.20M
Weighted Average Shares Outstanding (Diluted)
0.00 25.35M 20.31M 35.90M 38.20M
Currency in USD

GeneThera Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis